Ask AI

Redefining HCC Treatment in the Immunotherapy Era: Expert Insights, Multimodal Innovations, and Coordinated Care for Optimal Outcomes Across the Disease Continuum

Enhance your understanding of immunotherapies and targeted agents for the management of hepatocellular carcinoma (HCC). Learn how to effectively implement collaborative-care approaches and evolving guideline recommendations to improve patient care through a certified on-demand webcast, expert-authored ClinicalThought commentary, podcast, and downloadable slides.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Eisai and Merck Sharp & Dohme LLC.

Eisai

Merck Sharp & Dohme, LLC